Archive for the ‘biotech/medical’ category: Page 2297
Jul 29, 2018
Study finds evidence that leopard geckos can make new brain cells
Posted by Marcos Than Esponda in categories: biotech/medical, life extension, neuroscience
Published in Scientific Reports, this study is the first to provide evidence of new neuron formation—and the presence of stem cells—in the leopard gecko brain.
University of Guelph researchers have discovered the type of stem cell allowing geckos to create new brain cells, providing evidence that the lizards may also be able to regenerate parts of the brain after injury.
This finding could help in replacing human brain cells lost or damaged due to injury, aging or disease.
Continue reading “Study finds evidence that leopard geckos can make new brain cells” »
Jul 29, 2018
Why China’s premier used hit movie ‘Dying to Survive’ to push for cheaper cancer drugs
Posted by Derick Lee in categories: biotech/medical, entertainment
Billed as the Chinese answer to Dallas Buyers Club, the tear-jerking film Dying to Survive last week became Premier Li Keqiang’s new rallying cry for speeding up price cuts for cancer medications. It is an issue of such complexity that he has held two cabinet meetings about it in the past three months.
Li Keqiang has been trying to speed up price cuts for life-saving medication for months, and it’s a boon that the box-office hit has generated widespread awareness.
Jul 28, 2018
Lunar Eclipse: July 28 ‘blood moon’
Posted by Michael Lance in categories: biotech/medical, space
Watch on Rappler the longest total lunar eclipse of the century, and Mars will be right next to the eclipsing moon http://www.rappler.com/science-nature/earth-space/208321-how…nce-nature
Jul 28, 2018
XTPL ultra-precise Nanometric Printer receives Honorable Mention at Display Week 2018 I-Zone
Posted by Ole Peter Galaasen in categories: biotech/medical, information science, nanotechnology, solar power, sustainability, wearables
Closing in on molecular manufacturing…
http://xt-pl.com received an honorable mention from I-Zone judges for its innovative product that prints extremely fine film structures using nanomaterials. XTPL’s interdisciplinary team is developing and commercializing an innovative technology that enables ultra-precise printing of electrodes up to several hundred times thinner than a human hair – conducive lines as thin as 100 nm. XTPL is facilitating the production of a new generation of transparent conductive films (TCFs) that are widely used in manufacturing. XTPL’s solution has a potentially disruptive technology in the production of displays, monitors, touchscreens, printed electronics, wearable electronics, smart packaging, automotive, medical devices, photovoltaic cells, biosensors, and anti-counterfeiting. The technology is also applicable to the open-defect repair industry (the repair of broken metallic connections in thin film electronic circuits) and offers cost-effective, non-toxic, flexible industry-adapted solutions.
Jul 28, 2018
A Major Drug Company Now Has Access to 23andMe’s Genetic Data. Should You Be Concerned?
Posted by Derick Lee in categories: biotech/medical, genetics, privacy
Consumer genetic testing company 23andMe announced on Wednesday that GlaxoSmithKline purchased a $300 million stake in the company, allowing the pharmaceutical giant to use 23andMe’s trove of genetic data to develop new drugs — and raising new privacy concerns for consumers.
23andMe is partnering with big pharma company GlaxoSmithKline. Here’s what that means for consumer rights and genetic privacy.
Jul 27, 2018
Changes in Sperm RNA May Shape Future Generations, Scientists Warn
Posted by Genevieve Klien in categories: biotech/medical, ethics, satellites
While the rest of the world debates the ethics of designer babies, a team at the University of Massachusetts Medical School (UMass) have shown that we might not need CRISPR to change the genes of future generations. Their paper, released this week in the journal Developmental Cell, shows that things like diet and stress might affect some crucial genetic components of sperm, and that these tiny changes have real effects on how babies develop.
The same way rockets bound for outer space contain “payloads” like satellites, or astronauts who battle giant balls of urine, sperm are also like little rockets containing their own cargo: “small RNAs.” This study found that not only do RNA sequences play a crucial role in how genes get expressed early on in human development, but they can also be radically changed by the lifestyles of fathers. Things like diet, and in particular, stress can change the makeup of this crucial RNA cargo and lead to observable changes in offspring, says researcher Colin Conine, Ph.D., at UMass Medical School’s Rando Lab.
“Labs all over the world have been able to link changes in dad’s lifestyle to changes in RNA in the sperm, and then that leads to phenotypes in the offspring,” Conine tells Inverse. “Our study was one of the first to really look at how changes small RNAs affect early development. We wanted to ask, what are the first steps that lead to these phenotypes down the road?”
Jul 27, 2018
How Is AI Used In Healthcare — 5 Powerful Real-World Examples That Show The Latest Advances
Posted by Genevieve Klien in categories: biotech/medical, robotics/AI
Healthcare can be transformed with the innovation and insights of AI and machine learning. From robot-assisted surgery to virtual nursing assistants, diagnosing conditions facilitating workflow and analyzing images, AI and machines can help improve outcomes for patients and lower costs for providers.
Jul 26, 2018
Cancer cells destroyed with two antipsychotic drugs
Posted by Genevieve Klien in category: biotech/medical
A new study shows that the antipsychotics perphenazine and fluphenazine can successfully destroy cancer cells in cell cultures and rodents.
Jul 26, 2018
How artificial intelligence is changing the pharmaceutical industry
Posted by Alexandros El in categories: biotech/medical, information science, robotics/AI
But the great potential of artificial intelligence shall become fully clear when considering its possible applications to drug discovery. It seems an era ago since the Human Genome Project was completed in 2003; since then, sequencing capabilities and softwares for data analysis rapidly established themselves as the new paradigm for drug discovery thanks to the increasing availability of IT technologies and the institutional and governmental support to big data analytics’ policies.
The exponential growth of the market
The annual growth rate of the market of artificial intelligence for healthcare applications has been recently estimated by Global Market Insights to be 40% CAGR (Compounded Average Growth Rate) per year up to 2024, starting from a value on $ 750 million in 2016.
Continue reading “How artificial intelligence is changing the pharmaceutical industry” »